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774Intravascular ultrasound as a clinical adjunct for
carotid plaque characterization
Elizabeth Hitchner, MA,a Mohamed A. Zayed, MD, PhD,b George Lee, MD,b Doug Morrison, MS,b
Barton Lane, MD,c,d and Wei Zhou, MD,a,b Palo Alto and Stanford, Calif
Objective: Virtual histology intravascular ultrasound (VH IVUS) is valuable for estimating minimal lumen diameter and
plaque characterization. The clinical use of IVUS in carotid intervention is not well characterized. We aim to evaluate the
role of IVUS in carotid plaque characterization and determine whether it could be predictive of procedure-related
microemboli.
Methods: From July 2010, patients with severe carotid stenosis who underwent elective carotid stenting procedures were
prospectively enrolled. IVUS evaluation was performed before stent placement. Patient demographics, comorbidities, and
preoperative images were recorded. Comparison of pre- and postoperative diffusion-weighted magnetic resonance images
was used to identify the number of procedure-related microemboli. IVUS-derived minimal lumen diameter and vessel
wall plaque characteristics were collected. Univariate and multivariate logistic regressions were used to search for asso-
ciations between IVUS-derived VH data and incidence of microemboli.
Results: A total of 38 high-risk patients receiving carotid stenting were enrolled. Among them, 25 patients had type I
aortic arches and 17 of the patients were symptomatic (preoperative stroke or transient ischemic attack). VH IVUS data
did not show strong associations with microemboli, however, a trend was found between the area of ﬁbrous tissue and
median or more incidence of microemboli (P [ .099). IVUS-deﬁned vessel diameter maximum was associated with
median or more incidence of microemboli (P [ .042). In addition, median or more incidence of microemboli showed
trends with proximal common carotid artery calciﬁcation (P [ .056) and with being over the age of 80 (P [ .06).
Contralateral carotid occlusion or high-grade stenosis was associated with postoperative contralateral microemboli (P[
.036).
Conclusions: We demonstrate that periprocedural carotid IVUS is clinically feasible. VH IVUS may be helpful in better
understanding plaque morphology and determining optimal stent placement. However, its use in predicting micro-
embolization remains limited. (J Vasc Surg 2014;59:774-80.)Stroke is a leading cause of death worldwide and one of
the most common causes of permanent disability, making it
a signiﬁcant ﬁnancial burden on health care systems.1 For
high-risk patients, carotid artery stenting (CAS) is an alter-
native to carotid endarterectomy (CEA). Nevertheless,
distal embolization is a common procedural complication
during carotid interventions and occurs at a higher rate
in CAS patients than in patients undergoing CEA.2 We
and others have demonstrated that 20% to 70% of CAS
patients and 10% to 20% of CEA patients experienced
procedure-related microemboli evident on postoperative
magnetic resonance imaging (MRI).2-5 Despite an absence
of neurologic symptoms, these subclinical microembolithe Department of Vascular Surgerya and Department of Neuroradio-
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unclear whether carotid plaque characteristics can inﬂuence
microembolization in patients undergoing CAS.
Virtual histology intravascular ultrasound (VH IVUS;
Volcano Corporation, Rancho Cordova, Calif) has been
commonly used in coronary artery interventions9,10 to
facilitate accurate stent placement and stent apposition.
The use of IVUS in the carotid arteries, however, is not
a routine practice. VH IVUS identiﬁes four tissue subtypes
including ﬁbrous, ﬁbrofatty, necrotic, and dense calcium.
The Carotid Artery Plaque Intravascular Ultrasound Eval-
uation (CAPITAL) study from the Arizona Heart Insti-
tute11 outlines different plaque types based on the
location and arrangement of these tissue subtypes within
a lesion. The major descriptive plaque types include patho-
logic intimal thickening, ﬁbroatheroma, calciﬁed ﬁbroa-
theroma, thin-cap ﬁbroatheroma, and calciﬁed thin-cap
ﬁbroatheroma (CaTCFA). It is generally thought that
thin-capped plaques are more susceptible to rupture,
whereas plaques of mixed composition are more stable.
However, procedural outcome was not correlated to
IVUS ﬁndings in the CAPITAL study. There are only
limited studies that evaluated the feasibility of IVUS during
CAS and even fewer correlated IVUS ﬁndings with a more
sensitive clinical outcome measure, MRI-event microemboli-
zation. In this prospective study, we examined carotid plaque
morphology using VH IVUS and looked for associations
between plaque composition and microembolization.
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microembolization that is detected on 3T MRI. Our goal
is to determine whether the histologic and morphologic
information provided by VH IVUS can be used to facilitate
stent placement and improve the outcome of CAS
procedures.
METHODS
Patient selection. Patients with high-grade carotid
artery stenosis, based on duplex ultrasound criteria, who
were scheduled to undergo CAS procedures at the VA Palo
Alto Health Care System, were recruited to participate in
the study. Both symptomatic, with a >60% internal carotid
artery (ICA) stenosis, and asymptomatic patients, with
a >80% ICA stenosis were treated under the local standard
clinical practice guidelines. Carotid ultrasounds were per-
formed by an experienced registered vascular technologist
using a standard duplex ultrasound unit (Philips iu-22;
Philips Healthcare, Andover, Mass) equipped with a linear
7.5-MHz transducer. Diagnosis of carotid stenosis was
determined based on carotid ultrasound velocity criteria
and North American Symptomatic Carotid Endarterec-
tomy Trial (NASCET) criteria and conﬁrmed with preop-
erative magnetic resonance angiography evaluations. In
general, end diastolic velocity (EDV) >100 cm/s was
interpreted as an 80% or more stenosis.
Inclusion criteria required that the patient be of 40
years of age or older, able to undergo MRI, voluntarily
participates in the study, signs an informed consent docu-
ment approved by the Stanford Institutional Review Board,
and is available for follow-up imaging studies. All patients
were considered high risk for CEA, and the risk stratiﬁca-
tion was determined by board-certiﬁed vascular surgeons
and cardiologists. The anatomic high-risk criteria included
presence of tracheostomy, history of ipsilateral neck radia-
tion therapy, and prior radical neck dissection or CEA.
The medical high-risk criteria included myocardial infarc-
tion in the previous 3 months and signiﬁcant coronary
artery disease with reversibility on persantine-thallium or
oxygen-dependent chronic obstructive pulmonary disease.
Four patients were included who had VH IVUS recorded
but did not receive postoperative MRI because of nonclin-
ical reasons.
Carotid stenting procedure with IVUS. All proce-
dures were performed in an endovascular suite (GE Med-
ical Systems, Milwaukee, Wisc). Brieﬂy, upon securing
a guiding sheath in the common carotid artery, a selective
digital carotid angiogram was performed to conﬁrm the
degree of stenosis. A distal embolic protection device
(EPD; Emboshied Embolic Protection System; Abbot,
Santa Clara, Calif) was then placed in the mid to distal
cervical ICA. IVUS examination was then performed using
a Volcano s5VH Ultrasound Imaging System (Volcano
Corporation). A 5F Eagle Eye Gold Coronary Imaging
Catheter (Volcano Corporation) was advanced along the
0.014-inch wire. Once the catheter reached a relatively
normal segment of ICA distal to the lesion, the VH mode
was activated, and the catheter was withdrawn at a rate ofapproximately 1 mm/s until a relatively normal area of the
common carotid artery was reached. The morphology of
the lesion was recorded and analyzed ofﬂine. Next, a self-
expanding Food and Drug Administration-approved
carotid stent (Xact Carotid Stent System; Abbot) was
deployed across the carotid stenosis. Prestenting balloon
angioplasty was not routinely done, but poststenting
balloon angioplasty was always performed using either a 5-
or 6-mm-diameter angioplasty balloon. A completion
carotid angiogram was performed prior to capture of the
EPD to document the satisfactory result of the interven-
tion and to exclude thromboembolism proximal to the
EPD. After the EPD was captured, a cerebral angiogram
including lateral and anteroposterior views was obtained to
exclude acute cerebral embolism. Lastly, the groin punc-
ture site was routinely closed with a closure device.
Following carotid stenting procedures, the patients were
observed in an intensive care unit.
IVUS analysis. IVUS images were analyzed using
Volcano Imaging Analysis Software (Volcano Corporation)
to determine plaque composition and morphology. Vessel
and lumen borders were manually corrected and agreed
upon by two different readers for each patient. Plaque
composition data were automatically generated by the soft-
ware and included lumen and vessel areas, minimal lumen
and vessel diameters, plaque burden, media area, and pla-
que tissue area (necrotic, ﬁbrous, ﬁbrofatty, and calciﬁed).
Plaque composition was determined by averaging VH data
from a minimum of 10 frames surrounding the area of
highest stenosis. In addition, VH data and lumen diameter
calculations were recorded for the single IVUS frame
showing peak stenosis (minimal lumen). Lesion types
from the CAPITAL study11 were also used to descrip-
tively categorize plaque morphology for each patient by
determining the “worst plaque type” present, as outlined in
the second paragraph of the introduction.
MR imaging. Patients received MRI within 48 hours
following the carotid stenting procedure. Using a 3T
magnet, a diffusion-weighted sequence with an automati-
cally generated apparent diffusion coefﬁcient (ADC) map
was performed and used to identify incidence of procedure-
related microemboli. Although lesions seen on diffusion-
weighted imaging (DWI) sequence are not directly
correlated to the sizes of emboli, hypertensive signals on
DWI sequence indicate water diffusion between intracel-
lular and extracellular compartments, therefore, an
evidence of cell death. Images were interpreted by a
neuroradiologist who was blinded to the patient’s treat-
ment and IVUS-derived histologic data. Presence of a new
hyperintensity on DWI with corresponding hypointensity
on the ADC map was interpreted as a new microembolic
lesion. The number and location of new microemboli were
recorded for each patient.
Statistical analysis. Data were collected on an elec-
tronic spreadsheet and analyzed by a statistician using R
2.15.2.12 Univariate logistic regression was used to search
for positive associations between the incidence of micro-
emboli and clinical risk factors.Multivariate logistic regression
Table I. Demographics
Field Variable
No. (%)
(N ¼ 38)
Demographics Age $80 8 (21)
Coronary artery disease (with
reversibility on persantine-
thallium stress test)
18 (47)
Smoking (current) 9 (24)
Diabetes 18 (47)
Obesity (BMI >30) 13 (34)
Peripheral vascular disease 8 (21)
Chronic obstructive pulmonary
disease
6 (16)
Congestive heart failure 5 (13)
Hypercholesterolemia
(cholesterol >200 mg/dL)
31 (82)
Symptomatic 17 (45)
Anatomic
characteristics
Aortic arch type II/III 12 (32)
CCA calciﬁcation 10 (26)
Arch calciﬁcation 6 (16)
Contralateral occlusion/severe
stenosis
11 (29)
PSV (average) 369 cm/s
EDV (average) 128 cm/s
VH IVUS “worst
plaque type”
CaTCFA 16 (42)
Thin-cap ﬁbroatheroma 1 (3)
Calciﬁed ﬁbroatheroma 16 (42)
Fibroatheroma 4 (10)
Pathologic intimal thickening 1 (3)
BMI, Body mass index; CaTCFA, calciﬁed thin cap ﬁbroatheroma; CCA,
common carotid artery; EDV, end diastolic velocity; PSV, peak systolic
velocity; VH IVUS, virtual histology intravascular ultrasound.
Table II. Virtual histology intravascular ultrasound (VH
IVUS) histology
Tissue
Median or less
microemboli
(average,
SD mm2)
Median or more
microemboli
(average,
SD mm2)
Whole trace
(10 frames)
Fibrousa 13.77 6 3.26 16.61 6 8.39
Fibrofatty 6.05 6 3.01 6.19 6 3.12
Necrotic core 7.91 6 2.27 6.54 6 2.43
Dense calcium 3.59 6 1.45 3.79 6 1.90
Minimal
lumen
Fibrous 18.2 6 6.63 17.56 6 6.00
Fibrofatty 11.6 6 4.54 10.36 6 5.58
Necrotic core 6.58 6 3.99 7.66 6 4.29
Dense calcium 2.66 6 2.31 2.17 6 1.28
SD, Standard deviation.
aFibrous tissue demonstrated the greatest variation between the two
cohorts.
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between the incidence of microemboli and IVUS-derived
histology along with clinical risk factors. Incidence of micro-
emboli was grouped into quartiles and analyzed primarily
between those who were above and below the median
number of microembolic lesions. All P values reported are
one-sided Wald tests for positive values of logistic model
coefﬁcients.
RESULTS
From July 2010, 43 consecutive patients were enrolled
in the study, and 38 were included in the analysis. The ﬁve
patients that were excluded had no VH IVUS performed
during the procedure. VH IVUS was not performed in
three patients because of equipment issues and in two
because of the clinician’s decision of expediting the proce-
dure. All patients were male with an average age of 70
years. An overview of patient demographics revealed that
approximately one-quarter (24%) of the patients were
active smokers and that the majority of patients had hyper-
lipidemia (82%). Seventeen patients (45%) were symptom-
atic, either having experienced a recent preoperative stroke
or transient ischemic attack (Table I).
Anatomically, nearly two-thirds (66%) of the patients
had type I aortic arches, whereas 10 patients had a type
II arch, two patients had a type III arch, and one patient
had a bovine arch. The average ICA stenosis estimated
by ultrasound preoperatively was >80 (range, 65%-99%)
with a mean EDV of 128 cm/s. Eight patients demon-
strated preoperative microemboli on DWI indicating that
these patients had vulnerable lesions. Postoperatively,
microembolic lesions were found in all but two patients,
ranging from 1 to 22 distinct areas of hyperintensity on
DWI with corresponding areas of hypointensity on ADC
maps. The mean diameter of the lesions measured 1 to
5 mm in size. Notably, two patients had signiﬁcant
thrombus in the EPD following stent placement and
required aspiration to remove debris prior to EPD capture.
Neither of these patients exhibited postoperative neuro-
logic deﬁcits or other complications. All patients tolerated
the procedure well, with no signiﬁcant perioperative
complications that required extended hospitalization.
One patient exhibited postoperative neurologic symptoms
that resolved within 24 hours prior to discharge from the
hospital; this patient remained asymptomatic with a patent
repair site on subsequent follow-up evaluations.
Sixteen of the patients were found to have IVUS-
deﬁned CaTCFAs. Other plaque types identiﬁed are shown
in Table I. No statistical difference was found in the inci-
dence of median or more microemboli between patients
with CaTCFAs and those with presumably less vulnerable
plaque types (P ¼ .757). At the area of highest stenosis
identiﬁed with VH IVUS, the average lumen area was
7.57 mm2 (range, 3.52-19.42 mm2), and the average pla-
que burden was 85% (range, 65%-94%). Plaque composi-
tion was highly variable between patients. Histology
calculations from the whole tracing are shown in
Table II. For two patients, VH IVUS ﬁndings signiﬁcantlyinﬂuenced stent placement by the operating physician
(Fig). In these cases, VH revealed greater extension of
vulnerable plaque within the ICA than visualized by angi-
ography alone.
Univariate logistic regression revealed positive associa-
tions between clinical risk factors and median or more inci-
dence of microemboli (Table III). Speciﬁcally, a higher
incidence of microemboli showed trends with calciﬁcation
Fig. Virtual histology intravascular ultrasound (VH IVUS) can assist in proper stent placement. Additional vulnerable
regions were identiﬁed distal (A) and proximal (C) to the central lesion (B) initially visualized by angiogram (D). In
this case, two stents were placed (E) to cover a longer length based on these ﬁndings.
Table III. Univariate logistic regressions with median or
more microemboli
Risk factor P value Direction
Proximal CCA calciﬁcation .056 Positive
Age $80 .060 Positive
Preoperative microemboli .019 Positive
IVUS whole trace ﬁbrous area .099 Positive
IVUS whole trace lumen diameter minimum .057 Positive
IVUS whole trace vessel diameter maximum .042 Positive
CCA, Common carotid artery; IVUS, intravascular ultrasound.
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greater than 80 (P ¼ .06). Evidence of microemboli on
preoperative MRI, suggestive of a vulnerable lesion, was
associated with incidence of median or more microemboli
(P ¼ .019). In addition, patients with contralateral carotid
artery occlusion or high-grade stenosis were more likely to
incur contralateral microemboli (P ¼ .0363). No VH
IVUS data were associated with incidence of microemboli,
with the strongest correlation being the whole trace ﬁbrous
area (P ¼ .099). IVUS-derived vessel characteristics,
however, were associated with incidence of microemboli;
whole trace vessel diameter maximum (P ¼ .042) and
lumen diameter minimum (P ¼ .057) demonstrated posi-
tive associations and trends with median or more incidence
of microemboli, respectively.Multivariate model analysis showed that median or
more microemboli were associated with proximal common
carotid calciﬁcation (P ¼ .030) after adjusting for whole
trace dense calcium area (Table IV, A). Median or more
microemboli also occurred more often in octogenarians
in a model containing peak systolic velocity (P ¼ .041;
Table IV, B). Furthermore, contralateral occlusion or
high-grade stenosis demonstrated an association with the
incidence of contralateral microemboli after adjusting for
ipsilateral peak systolic velocity and preoperative symptoms
(P ¼ .028; Table IV, C).
DISCUSSION
This prospective study demonstrates that VH IVUS
can provide insight for carotid plaque characterization
during CAS procedures. We demonstrate that age $80
years and severe common carotid artery calciﬁcation were
each associated with a higher incidence of procedure-
related cerebral microemboli. For the ﬁrst time in the liter-
ature, we also found evidence that contralateral severe
carotid stenosis or carotid occlusion was associated with
postoperative contralateral microemboli, suggesting an
alternative embolic mechanism.
The information on utilization of VH IVUS for carotid
disease assessment is limited. VH IVUS identiﬁes four
tissue subtypes, and the CAPITAL study from the Arizona
Heart Institute11 outlines different plaque types based on
the location and arrangement of these tissue subtypes
Table IV. A, Proximal common carotid calciﬁcation is associated with incidence of microemboli
Univariate
P value
Multivariate
OR
Multivariate
OR 2.5 %
Multivariate
OR 97.5 %
Multivariate
P value
(Intercept) .5 0.1837 0.0163 1.3998 .9369
Proximal CCA calciﬁcation .0561 5.2905 1.0307 36.2777 .0301
Whole trace DC area .2232 1.3294 0.8343 2.252 .1254
CCA, Common carotid artery; DC, dense calcium; OR, odds ratio.
Table IV. B, Age is associated with incidence of microemboli
Univariate P value Multivariate OR Multivariate OR 2.5 % Multivariate OR 97.5 % Multivariate P value
(Intercept) .5 36.4164 2.4972 1267.0121 .01
Age >80 .06037 7.9735 0.9296 116.9625 .0407
PSV .9906 0.9888 0.9782 0.9963 .9938
OR, Odds ratio; PSV, peak systolic velocity.
Table IV. C, Contralateral occlusion is associated with incidence of contralateral microemboli
Univariate
P value
Multivariate
OR
Multivariate
OR 2.5 %
Multivariate
OR 97.5 %
Multivariate
P value
(Intercept) .153 5.5299 0.3204 203.4085 .1381
Asymptomatic .4829 1.4833 0.2143 10.7968 .3411
Contralateral occlusion/severe stenosis .03629 7.0263 1.1417 71.0328 .028
PSV .9212 0.9941 0.9862 1.0004 .9532
OR, Odds ratio; PSV, peak systolic velocity.
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demonstrates that VH IVUS is feasible during CAS proce-
dures.11,13,14 In addition, we explored whether IVUS-
derived plaque characteristics can help predict the risk of
perioperative cerebral microembolization. Similar investi-
gations are limited, and to our knowledge, there are only
three other studies14-16 that have assessed the capacity
for IVUS to help predict plaque stability and embolic
potential. Unlike other studies, we used a 3T magnet for
detection of microemboli and explored other patient char-
acteristics predictive of microembolization in this high-risk
patient population. Similar to other studies, we found no
association between necrotic core and the incidence of
microemboli.17 Unlike Timeran et al,15 but consistent
with Yamada’s study,16 we did not ﬁnd an association
between lesion calciﬁcation and incidence of microemboli.
We also did not observe any increase in embolic potential
from carotid lesions with high ﬁbro-fatty content. This
may in part be due to differences in how we acquired
and analyzed data for total plaque composition. We evalu-
ated the 10 frames surrounding the site of minimal luminal
areada technique that is variable between studies. Plaque
composition revealed by VH was highly variable between
patients, making it difﬁcult to identify a unique plaque
signature for the likelihood of microembolization. Further-
more, our study used a 3T MRI for detection of postopera-
tive microemboli. While all related studies have moderately
differing results, each group has independently found noassociation between necrotic core and incidence of micro-
emboli. Admittedly, only nine of our patients had greater
than 25% necrotic core at the area of highest stenosis.
Although patients with more embolic lesions had
a slightly higher ratio of dense calciﬁed area, IVUS-derived
dense calcium area was not associated directly with micro-
emboli. When we looked beyond VH IVUS ﬁndings, the
presence of calciﬁcation in the proximal common carotid
artery was associated with microembolization, suggesting
that wire and catheter manipulation within the common
carotid artery is a potential source for distal embolization.
In our multivariate analysis, we also found that patients
$80 years old were more likely to experience a high number
of microemboli postprocedurally. With only eight patients
over age of 80 years, our multivariate model showed a large
odds ratio, suggesting that age $ 80 had an unreliable asso-
ciation. Nonetheless, other studies have demonstrated18,19
that age is an important risk factor in carotid interventions.
Another signiﬁcant ﬁnding independent of the VH
IVUS data were an association between contralateral
carotid occlusion or severe stenosis and postoperative
contralateral microemboli (Table IV, C). One might
expect to have decreased contralateral emboli in patients
with severe contralateral carotid stenosis, as the stenotic
artery can function as a biological ﬁlter to prevent proximal
arch emboli from crossing a severe stenotic lesion. In our
study, patients exhibiting contralateral microemboli devel-
oped on average twice the number of microemboli as
JOURNAL OF VASCULAR SURGERY
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erate that patients with contralateral severe stenosis or
occlusion are at higher risk for microembolization. We
have previously proposed a model for this pathway20 and
suggested that intracranial pathways, such as anterior and
posterior communicating arteries, were the major highways
for contralateral microemboli originating from the inter-
vened ipsilateral carotid arteries. It is also possible that
poor cerebral ﬂow in the contralateral hemisphere impairs
the ability of the brain to wash out the minute embolic
materials, hence, increasing the incidence of microemboli.
Further investigations are necessary to further understand
the pathophysiology of contralateral microemboli in these
patients. Although we did not seek to address this speciﬁ-
cally in the present study, this ﬁnding provides further
insight into the source of such microemboli. Prior studies
have focused primarily on ipsilateral microemboli, however,
our results indicate that contralateral microemboli should
not be ignored.
Admittedly, there are several limitations to this study.
Most notably, only two of the patients in our study did
not develop any postprocedural microemboli. We used
a 3T MRI scanner for lesion detection. The powerful
MR magnet itself did not increase the incidence of micro-
emboli but increased the sensitivity of detecting microem-
bolic lesions. It is possible that the high incidence we
observed in this study was due in part to the sensitive
detecting method. However, it is still unclear why we
observed such a high rate of microembolization among
this group of CAS patients. We are reasonably certain
that our high microembolic rate was largely due to patient
selection and our stenting procedure modiﬁcation, alth-
ough we cannot conﬁrm this possibility. Multiple prior
studies have conﬁrmed that the use of VH IVUS in the
carotid arteries is safe21,22 and suggest that the device itself
is not a cause for increased embolization. We speculate that
our high microembolic rate may in part be due to a cohort
effect. Alternatively, our high rate could be due to perform-
ing more aggressive poststenting balloon dilation, which
was intended to reduce future in-stent restenosis and
inducing more microemboli in what has been described
as the “cheese grater” effect.23 Another variable that
should be considered is the timing of carotid intervention
and how this might inﬂuence plaque morphology; one
previous study using VH IVUS during CAS found that
incidence of vulnerable plaques was dependent on how
closely the procedure was performed to the index ischemic
episode.24 In our study, the majority of the patients had
severe stenosis with a mean EDV of 128 cm/s, 45%
patients were treated for symptomatic carotid stenosis,
and 21% had preoperative microemboli, suggesting that
this cohort of patients and lesions had a high embolization
risk to start with. Although this study is one of the larger
studies evaluating the utility of IVUS in carotid stenting,
the total number of subjects is still small. We are limited
with our small sample size, particularly in regard to our
multivariate analysis. For this reason, we can only report
associations between our variables. Although statisticalsigniﬁcance was not reached because of our small sample
size, two important trends with a P value <.06 were
discussed.
CONCLUSIONS
VH IVUS can be used to characterize lesion
morphology during CAS, however, its ability to predict
microembolization remains limited. Nevertheless, VH
IVUS can provide helpful insight in regard to the
morphology of the lesion, which may inﬂuence stent place-
ment and improve procedural outcomes. VH IVUS can
reveal areas of stenosis and calciﬁcation that is difﬁcult to
discern by angiogram alone. Future studies will be neces-
sary to determine the extent to which VH IVUS can be
used to determine plaque morphology in the carotid
arteries in relation with incidence of microemboli.
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